Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$236.97 USD

236.97
597,597

-1.09 (-0.46%)

Updated Oct 3, 2024 03:59 PM ET

After-Market: $232.00 -4.97 (-2.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (178 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Medtronic Stock Dips on Preliminary Sales Drag, CRHF to Grow

Medtronic's (MDT) latest preliminary sales update for the second quarter of fiscal 2018 holds the market in a bleak light.

    Ecolab (ECL) to Refinance $375M Worth of Notes, Reduce Debt

    Ecolab (ECL) plans to reduce debt by refinancing notes with a lower coupon rate.

      Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength

      Luminex's (LMNX) collaborative agreements with several companies should help expand the adoption of its products.

        Intuitive Surgical (ISRG) to Gain From Procedural Business

        Intuitive Surgical's (ISRG) sales to gain from on da Vinci system and procedural growth in general surgery, oncology, urology and gynecology.

          LabCorp Reports New Use of Agilent's Cancer Diagnostic Test

          The testing of the clinical studies needed to approve PD-L1 IHC 28-8 pharmDx assay's new indications were performed at LabCorp's (LH) Center for Molecular Biology and Pathology laboratory.

            Here's Why Investors Should Buy Myriad Genetics Right Now

            Myriad Genetics' (MYGN) recent collaborations are encouraging. Also, the company banks on the GeneSight and EndoPredict portfolios.

              Illumina Introduces NextSeq 550Dx, Updates Use of MiSeqDx

              Illumina (ILMN) expands NGS platform. The company has a solid diagnostic NGS portfolio, which includes NextSeq 550Dx and MiSeqDx.

                Myriad Genetics' Latest Alliance to Boost GeneSight Reach

                Myriad Genetics' (MYGN) tie-up with Department of VA to assess the effectiveness of GeneSight test buoys optimism. Also, favorable results might boost GeneSight's customer base

                  Here's Why Investors Should Buy Luminex (LMNX) Right Now

                  Luminex (LMNX) continues to grow strong on innovation and product launches.

                    Haemonetics (HAE) Grows on Strong Plasma, Competition Rife

                    Despite stiff competition, Haemonetics (HAE) grows on the back of its Plasma and Haemonetics Management franchises.

                      Align Technology at 52-Week High: What's Driving the Stock?

                      Align Technology (ALGN) consistently invests in R&D for product innovation.

                        7 Stocks with Recent Price Strength to Boost Your Portfolio

                        One should primarily look for stocks that are witnessing price increase. Actually, stocks seeing price strength recently have a high chance of carrying the momentum forward.

                          Align Technology, Tesla, Apple, Starbucks and Unilever highlighted as Zacks Bull and Bear of the Day

                          Align Technology, Tesla, Apple, Starbucks and Unilever highlighted as Zacks Bull and Bear of the Day

                            Becton Dickinson (BDX) in Focus: Stock Moves 7.7% Higher

                            Becton Dickinson (BDX) saw its shares rise nearly 8% on the day after the company posted better-than-expected third-quarter results.

                              Kevin Cook headshot

                              Bull of the Day: Align Technology (ALGN)

                              This growth story with teeth clearly keeps surprising investors and Wall Street as it delivers another record quarter

                                Align Technology (ALGN) Gains on InvisAlign, Competition Rife

                                Align Technology (ALGN) continues to gain from strength in the InvisAlign space.

                                  Zacks.com featured highlights PRA Health Sciences, Align Technology, Adobe Systems and Par Pacific Holdings

                                  Zacks.com featured highlights PRA Health Sciences, Align Technology, Adobe Systems and Par Pacific Holdings

                                    Kevin Cook headshot

                                    Deep Learning Goes to Wall Street

                                    Fintech innovations are changing investing tools and behavior in powerful ways that you must begin to explore.

                                      Buy These 4 Top-Ranked Profitable Stocks in November

                                      A profitable company is able to meet all its operating costs and offer stupendous returns to its investors.

                                        Align Technology (ALGN) Q3 Earnings Top on Invisalign Sales

                                        An extremely strong summer teen season drives Align Technology's (ALGN) Invisalign growth within the global teen market in the third quarter.

                                          Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?

                                          Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q3.

                                            Henry Schein (HSIC) Q3 Earnings to Show Growth in All Lines

                                            Henry Schein (HSIC) likely to gain on strength across all business segments in Q3.

                                              What's in Store for Penumbra (PEN) Stock in Q3 Earnings?

                                              Penumbra (PEN) is expected to gain from strong performance by its neuro and peripheral vascular arms in Q3.

                                                Can Companion Animal Group Drive IDEXX's (IDXX) Q3 Earnings?

                                                IDEXX Laboratories (IDXX) is poised to gain from strength in its Companion Animal Group business in Q3.

                                                  Will Invisalign Drive Align Technology's (ALGN) Q3 Earnings?

                                                  Align Technology (ALGN) is poised to gain from strength in the Invisalign space in Q3.